Ruiyuan Fund increased its holdings of GUSHENGTANG (02273) by 70,000 shares at a price of approximately HK$31.96 per share.
On April 23, Ruiyuan Fund increased its holdings of Gusu Pharmaceutical (02273) by 70,000 shares, valued at approximately 31.9643 Hong Kong dollars per share, with a total amount of around 2.2375 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on April 23, Ruiyuan Fund increased its holdings of GUSHENGTANG (02273) by 70,000 shares, with a price of 31.9643 Hong Kong dollars per share, totaling approximately 2.2375 million Hong Kong dollars. After the increase, the new number of shares held is 19.2639 million, with a new holding percentage of 8.02%.
Related Articles
Kingfa Sci. & Tech. (600143.SH) is planning to launch an employee stock ownership plan in 2026.
Kingfa Sci. & Tech. (600143.SH) plans to issue up to 39,279,970 restricted shares.
New Stock News | Red Avenue New Materials Group (603650.SH) submits its application to the Hong Kong Stock Exchange. In the first nine months of 2025, its sales revenue in the Chinese semiconductor photoresist market ranked first among Chinese suppliers.
Kingfa Sci. & Tech. (600143.SH) is planning to launch an employee stock ownership plan in 2026.
Kingfa Sci. & Tech. (600143.SH) plans to issue up to 39,279,970 restricted shares.
New Stock News | Red Avenue New Materials Group (603650.SH) submits its application to the Hong Kong Stock Exchange. In the first nine months of 2025, its sales revenue in the Chinese semiconductor photoresist market ranked first among Chinese suppliers.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
